All Stories: drug pricing

Pharmaceutical has agreed to pay more than $7 million to settle allegations that it fixed the prices of several medicines

U.S. senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at a Senate hearing on the rising costs of prescription medicines.

Sanofi and Regeneron Pharmaceuticals said that they will slash the US list price of their potent but expensive cholesterol fighter Praluent